Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study

BACKGROUND: Bacillus Calmette-Guérin (BCG) is currently the most clinically effective intravesical treatment for non–muscle-invasive bladder cancer (NMIBC), particularly for patients with high-risk NMIBC such as those with carcinoma in situ. BCG treatments could be optimized to improve patient safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Plasek, Joseph, Weissert, John, Downs, Tracy, Richards, Kyle, Ravvaz, Kourosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277393/
https://www.ncbi.nlm.nih.gov/pubmed/34156341
http://dx.doi.org/10.2196/25800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277393/
https://www.ncbi.nlm.nih.gov/pubmed/34156341
http://dx.doi.org/10.2196/25800

Ejemplares similares